CMS cancels 315,000 Obamacare enrollments in anti-fraud push
Federal health officials are removing hundreds of thousands of Affordable Care Act marketplace enrollments as the Trump administration intensifies scrutiny of eligibility and subsidy payments. The action affects coverage tied to about 760,000 people and the White House task force says it could save roughly $2.2 billion in taxpayer-funded subsidies.
Highlights
- CMS canceled roughly 315,000 Affordable Care Act marketplace enrollments in May, affecting about 760,000 people, citing widespread suspected fraud.
- CMS is verifying the eligibility of an additional 419,000 enrollees for legal residency and income thresholds, following a White House Task Force anti-fraud initiative.
- A June ASPE report estimates nearly half of unprecedented Obamacare enrollment growth from 2021 to 2024 may be improper or fraudulent, raising concerns for insurers and subsidy policy.
Enrollment crackdown and verification effort
As reported by CNBC, citing the Centers for Medicare and Medicaid Services, the agency said it canceled roughly 315,000 Affordable Care Act marketplace enrollments last month, covering about 760,000 people, after alleging widespread fraud and improper sign-ups in the program.CMS also said it is verifying roughly 419,000 people to confirm they are legal U.S. residents and meet income thresholds required to receive benefits through the public exchanges, also known as Obamacare. Vice President JD Vance's White House Task Force to Eliminate Fraud led the cancellations, and Vance said at a Tuesday briefing that the Biden administration had allowed a system that enabled fraudulent enrollment practices.
The agency has not specified how many of the canceled enrollments involved people who were actually ineligible for coverage, or whether prior checks had failed to confirm eligibility. CMS Administrator Dr. Mehmet Oz also said during the briefing that about 35% of people currently in the Obamacare system have never used the program for prescriptions or doctor visits.
Policy context and market impact
The enforcement move comes as the Trump administration is making broader allegations of fraud across U.S. health programs and tightening funding and eligibility standards in Medicaid. Oz said ACA marketplace subsidies became more attractive to bad actors during the Covid-19 pandemic, when federal spending rose sharply and enrollment expanded from about 10 million people before COVID-19 to roughly 22 million afterward.A June report from the Assistant Secretary for Planning and Evaluation said Obamacare plans saw unprecedented enrollment growth from 2021 to 2024, with nearly half of that increase suspected to be improper, phantom, or fraudulent. The report defined improper or fraudulent enrollment as cases in which individuals misstated income to gain access to free plans.
The rise in sign-ups followed enhanced subsidies under the American Rescue Plan passed in 2021, which lowered health coverage costs during the pandemic. Those broader tax credits were later extended but expired at the end of 2025, increasing premiums for many people covered through Affordable Care Act exchanges; the same report estimates that 19.2 million Americans are currently enrolled in Obamacare plans.
Our earlier article on GLP-1 therapy coverage explained how soaring drug costs are forcing insurers and employers to rethink whether and how broadly to include these treatments in benefit plans. We noted that while clinical evidence is expanding and could eventually reduce chronic-disease burden, the near-term hit to pharmacy budgets and frequent switching between health plans make coverage decisions and savings uncertain.